Blog
News
All services
EN
ES
EN
ES
+34 91 277 10 76
Contact us
Azierta
About Us
Meet Our Team
Contact us
Services
Pharmacovigilance
ICSR Management
EudraVigilance Registration & Support
XEVMPD, Art. 57
Safety Reports
Signal Detection
QPPV support
Pharmacovigilance Quality system
PSMF and Pharmacovigilance agreements
Vigilazierta: Safety database
Regulatory Affairs
Products registration
Dossiers compilation
Post-authorization support
IDMP – Identification of Medicinal Products
Veterinary Medicines Regulation Services
GxP Compliance & Safety
Toxicological Evaluation of Impurities and Risk Analysis
Toxicology reports
Biosafety Support
REACH Compliance Support- CLP
GxP Support: Advice & Implementation of Quality Systems
ISO Compliance Support
Medical Cannabis Consultancy
Scientific Information
Digital, Science & Growth
Digital Strategy
Content Marketing
Software Solutions
Data & Analytics
Audit & Certification
GxP Audits
Supplier Audit Reports
Clinical Analysis Laboratories Audits
Audits for Compliance of Medical Devices
Medical Cannabis Audits
Data Integrity Audits
Internal Audits
Azierta Care
Cosmetics
Food Supplements
Medical Devices
Strategy & Intelligence
Life Science Investment Consulting
Life Science Business Development
Next Generation Regulatory Intelligence
Translational Medicine and Clinical Development
Next-generation Medical Affairs
Integrated Programs
Animal Health
Biopharma
Climate & Environmental
Quality Management System
Landing in Europe
Medical Cannabis
Removal of Titanium dioxide
Vigilazierta: Safety Database
Careers
Azierta Associates
Auditors Cloud
Academy
Contact Us
e-Consulting
e-Consulting
May 27, 2020
/
/
0 Comments
XEVMPD
Art. 57
XEVMPD
Art. 57
Management their current Extended EudraVigilance medicinal product…
Share this post with your friends
Facebook
Twiter
Linkedin
Prev Post
EudravigilanceRegistration & Support
Next Post
SafetyReports
